A.II.1 was diagnosed with CLL at the age of 30, with a CD5+, CD23− (atypical for CLL) population of monoclonal B cells without IGHV mutation or 11;14 translocation. This evidence concerns the gene FCER2 and B-cell chronic lymphocytic leukemia.